Cancer vaccine - CEL-SCI/Max Delbruck Center
Alternative Names: Breast cancer vaccine - CEL-SCI/Max Delbruck Center; Colon cancer vaccine - CEL-SCI/Max Delbruck CenterLatest Information Update: 31 Dec 2021
At a glance
- Originator CEL-SCI Corporation; Nonindustrial source
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Breast cancer; Colorectal cancer
Most Recent Events
- 22 Nov 1999 New profile
- 22 Nov 1999 Preclinical development for Breast cancer in Germany (Parenteral)
- 22 Nov 1999 Preclinical development for Colorectal cancer in Germany (Parenteral)